¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"point outside field"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • field defect
    ½Ã¾ß°á¼Õ
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÁú¼º
  • field survey
    ÇöÁöÁ¶»ç
  • field test
    ½ÇÁõ°Ë»ç
  • field uniformity
    Á¶»ç¿µ¿ª±ÕÀϼº, Á¶»ç¸é±ÕÀϼº
  • fringe field
    ÁÖº¯¿µ¿ª
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • geometric field separation
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ªºÐ¸®
  • gradient magnetic field
    ±â¿ï±âÀÚ±âÀå, °æ»çÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå
  • high field magnetic resonance scanner
    °íÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸éÀÚ¼®
  • irradiation field
    ¹æ»ç¼±Á¶»ç¿µ¿ª, ¹æ»ç¼±ÂØÀÓ¿µ¿ª
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
  • confrontation field test
    ´ë¸é½Ã¾ß°Ë»ç
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°áÇÔ
  • constant field equation
    Á¤ÀüÀ广Á¤½Ä
  • dark field microscope
    ¾Ï½Ã¾ßÇö¹Ì°æ
  • dark field microscopy
    ¾Ï½Ã¾ßÇö¹Ì°æ°Ë»ç
  • dark-field illumination
    ¾Ï½Ã¾ßÁ¶¸í
  • diplopia field
    º¹½Ã½Ã¾ß, °ãº¸Àӽþß
  • field defect
    ½Ã¾ß°á¼Õ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • visual field defect
    ½Ã¾ß°á¼Õ
  • electric field
    Àü±âÀå
  • magnetic field effect
    ÀÚ±âÀåÈ¿°ú
  • pulsed-field gel electrophoresis
    °£Ç濵¿ª°ÖÀü±âÀ̵¿
  • visual field examination
    ½Ã¾ß°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • point ³ª puntcum
    Á¡(ïÇ).
  • posterior focal point
    ÈÄÃÊÁ¡(ý­õ¥ïÇ).
  • pressure point
    ¾Ð¹ÚºÎÀ§(¡­Ý»êÈ), ¾ÐÅëÁ¡ (¡­ïÇ).
  • pressure point
    ¾Ð¹ÚºÎÀ§(äâÚÞÝ»êÈ), ¾ÐÅëÁ¡(äâ÷ÔïÇ)
  • primary focal point
    Á¦ÀÏÃÊÁ¡
  • principal point
    ÁÖÁ¡(ñ«ïÇ) ½ÃÃà(ãÊõî)ÀÇ .
  • principal point
    ÁÖÁ¡
  • radiant point
    ¹æ»çÁ¡
  • range of point
    ¿­Á¡(æïïÇ).
  • reference point
    ±âÁØÁ¡
  • reflection point
    ¹Ý»çÁ¡(ÚãÞÒïÇ).
  • remote point
    ¿øÁ¡(êÀïÇ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • geometrical field
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ª
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå(ñìæ³íÞ).
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸é ÀÚ¼®
  • illumination, dark-field
    ¾Ï½Ã¾ßÁ¶¸í
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • infinite field
    ¹«ÇÑü(ËḬ̧̂).
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • inverted Y field
    ¿ª Y Á¶»ç¿µ¿ª
  • irradiation field
    Á¶»ç¿µ¿ª
  • irregular field
    ºÎÁ¤ÇüÁ¶»ç¿µ¿ª
  • kinetic visual field
    µ¿Àû½Ã¾ß
  • least splitting field
    ÃÖ¼ÒºÐÇÒü.
  • low field MR scanner
    ÀúÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CFSE crystal field stabilization energy
CLD chloride diarrhea; chronic liver disease; chronic lung disease; congenital limb deficiency; crystal ...
CVF cardiovascular failure; central visual field; cervicovaginal fluid; cobra venom factor
DFC developmental field complex; dry-filled capsule
DFD defined formula diets; developmental field defect; diisopropyl phosphorofluoridate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
I.E.P. isoelectric point
I.P. isoelectric point
LIP lower inflection point
mbr major break point region
P.I. point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • distal point therapy
    ¿øµµ ÃëÇ÷ ¿ä¹ý
  • equivalence point
    ´ç·® Á¡
  • fixed point
    °íÁ¤Á¡
  • focal point
    ÃÊÁ¡
    ºûÀÌ Áý±¤ ·»Á ÅëÇØ Áö³ª°¥ ¶§ ±¤¼ÓÀÌ ÃÖ´ëÇÑ ³óÃàµÈ À§Ä¡.
  • freezing point depression
    ¾î´Â Á¡ °­ÇÏ
  • idiopathic trigger point mechanism
    Ư¹ß¼º ¹ßÅëÁ¡ ±âÀü
  • itchy point
    ¼Ò¾çÁ¡
  • jugal point
    Çù°¢ Á¡
    ÃøµÎ µ¹±â¿Í Çù°ñÀÇ ¾Õ ÂÊ ³¡ÀÇ À§ °¡ÀåÀÚ¸®°¡ À§·Î ³¯Ä«·Ó°Ô ±¸ºÎ·¯Áö´Â ÁöÁ¡.
  • jugomaxillary point
    Çù»ó¾ÇÁ¡
  • lacrimal point
    ´©Á¡
  • latent myofascial trigger point
    ÀáÀ缺 ±Ù¸· ¹ßÅëÁ¡
    ÃËÁø¿¡ ÀÇÇØ ÅëÁõÀÌ ³ªÅ¸³ª´Â °ÍÀ» Æ÷ÇÔÇÏ¿© Ȱµ¿¼º ±Ù¸· ¹ßÅëÁ¡ÀÇ ¸ðµç Ư¼ºÀ» °¡ÁöÁö¸¸ Àڹ߼ºÀÇ ÀÓ»óÀû ÅëÁõÀ̳ª Áõ»óÀÇ ¿øÀÎÀÌ µÇÁö´Â ¾Ê´Â ±Ù¸· ¹ßÅëÁ¡.
  • latent trigger point
    ÀáÀ缺 ¹ßÅëÁ¡
  • leak-point pressure
    ´©ÃâÁ¡ ¾Ð·Â
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • linguo-pulpo-axial point angle
    ¼³Ãø ¼öÃø ÃàÃø ÷°¢
    3°³ÀÇ ¿Íµ¿º®ÀÌ ¼­·Î ¿¬Á¢µÇ¾î ÀÌ·ç¾îÁö´Â Á¡»óÀÇ °¢À¸·Î¼­ ¿Üº®ÀÎ ¼³¸éº®°ú ³»º®ÀÎ ¼öº®, Ãøº®ÀÌ ÇÕÇØÁ®¼­ ÀÌ·ç¾îÁø °¢ÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
field identification <zoology> The determination of the taxonomic identity of an individual specimen, under field conditions, often with the aid of keys etc.
See: Identification.
(09 Jan 1998)
field ion microscope <instrument> Type of microscopy in which the specimen is illuminated with ions, often gallium ions, that are focussed electrostatically. The ions remove components of the specimen, lower atomic masses first. These are imaged and provide information on elemental distribution with a resolution of perhaps 30 nm.
(18 Nov 1997)
field lens <physics> The lower lens in an ocular, the lens nearest the object field.
(05 Aug 1998)
field lines <radiobiology> Lines in space along which a field is either changing or not changing (depends on the kind of field) but which help to create diagrams which characterise the behaviour and effects of the field. For instance, electric field lines run in the direction that the electric field will push charged particles, the strength of the field is proportional to the density of the field lines. On the other hand, the magnetic force pushes particles in a direction perpendicular to both the particle's velocity and the direction of the magnetic field line.
(09 Oct 1997)
field of consciousness The content of awareness at any given moment.
(05 Mar 2000)
field of fixation In ophthalmology, the angular distance around which the line of fixation can be turned.
(05 Mar 2000)
field of view <microscopy> The extent of the visible image field that can be seen.
(05 Aug 1998)
field planes <microscopy> The set of planes in a microscope adjusted for Kohler illumination that are conjugate with the focused specimen. They include the plane of the specimen, the field diaphragm, the intermediate image plane, and the image on the retina, photographic emulsion, or the faceplate of the video pickup device.
(05 Aug 1998)
field-reversed configuration <radiobiology> A compact torus produced in a theta pinch and having (in principle) no toroidal field. The potential advantages for a fusion reactor include a simple (linear) machine geometry, an average plasma pressure close to the confining field pressure, and physical separation of formation and burn chambers. The are predicted to be violently unstable to tilting, but this is rarely observed.
(09 Oct 1997)
field shaping coils <radiobiology> Type of poloidal field coils (in a tokamak) which create magnetic fields which shape and control the plasma. Used to constrain horizontal and vertical displacements of the plasma, as well as (in some configurations) produce non-circular plasma cross-sections (poloidal cross-section) and/or create one or more divertor separatrices.
(09 Oct 1997)
Field's rapid stain <technique> A stain to permit rapid positive diagnosis of malaria in endemic areas by using thick films; it employs methylene blue and azure B in a phosphate buffer, with the preparation counterstained by eosin in a phosphate buffer.
(05 Mar 2000)
field survey The planned collection of data among noninstitutionalised persons in the general population.
(05 Mar 2000)
field-vole A species of field mouse (Microtus montebelloi), normal host of Leptospira hebdomadis, the cause of a type of leptospirosis resembling infectious mononucleosis.
(05 Mar 2000)
free field A field (three-dimensional space) in a homogeneous, isotropic medium free from boundaries; in practice, a field in which boundary effects are negligible.
(05 Mar 2000)
alveolar point The most anterior point on the maxillary alveolar process in the midline.
Synonym: alveolar point, prostheon.
Origin: G. Ntr. Of prosthios, foremost
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • saturation point
    Æ÷È­Á¡;Àγ»(ÂüÀ»¼º)ÀÇ ÇѰèÁ¡
  • set point
    ¼¼Æ® Æ÷ÀÎÆ®(¼¼Æ®ÀÇ ½ÂÆÐ¸¦ Á¤ÇÏ´Â ÇÑ Á¡)
  • setting point
    ºùÁ¡;ÀÀ°íÁ¡
  • starting point
    Ãâ¹ßÁ¡;±âÁ¡
  • strong point
    ÀåÁ¡;°ÅÁ¡;¿äÁö
  • talking point
    È­Á¦
  • turning point
    º¯È¯Á¡;Àü(ȯ)±â;À§±â
  • vanishing point
    ¼Ò½ÇÁ¡;¹°°ÇÀÌ ´ÙÇÏ´Â ¼Ò¸êÁ¡
  • vowel point
    (È÷ºê¸®¾î,¾Æ¶ø¾î µîÀÇ)¸ðÀ½ ºÎÈ£
  • yield point
    Ç׺¹Á¡;ź¼ºÇѰ踦 ³Ñ¾î¼­ µÇµ¹¾Æ°¡Áö ¸øÇÏ´Â Á¡
  • field
    ÀüÅõ,ÅõÁö,½Î¿ì´Ù,´ÙÅõ´Ù
  • Field Marshal
    À°±º ¿ø¼ö
  • Field prize
    Çʵå»ó
  • brick field
    º®µ¹°øÀå
  • center field
    ¼¾ÅÍ(ÀÇ ¼öºñÀ§Ä¡)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á